Association between HMW adiponectin, HMW-total adiponectin ratio and early-onset coronary artery disease in Chinese population

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 392-397

  Wang, Ying ^a   Zheng, Aihua ^a   Yan, Yunsheng ^a   Song, Fei ^a   Kong, Qianran ^a   Qin, Shu ^a   Zhang, Dongying ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Coronary atherosclerosis; Early onset coronary artery disease; Gensini score; HMW adiponectin; HMW total adiponectin ratio

Indexed keywords

ADIPONECTIN; HIGH MOLECULAR WEIGHT ADIPONECTIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENSINI SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; MOLECULAR WEIGHT; ONSET AGE;

ADIPONECTIN; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HUMANS; MOLECULAR WEIGHT;

EID: 84921645049     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.910     Document Type: Article

References (37)

1. Hauser E.R., Mooser V., Crossman D.C., et al. Design of the genetics of early onset cardiovascular disease (GENECARD) study. Am Heart J 2003, 145:602-613.
2. Villarreal-Molina M.T., Antuna-Puente B. Adiponectin: anti-inflammatory and cardioprotective effects. Biochimie 2012, 94:2143-2149.
3. Ouchi N., Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chimica Acta; Int J Clin Chem 2007, 380:24-30.
4. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Medicine 2001, 7:941-946.
5. Matsuda M., Shimomura I., Sata M., et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. JBiol Chem 2002, 277:37487-37491.
6. Pischon T., Hu F.B., Girman C.J., et al. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis 2011, 219:322-329.
7. Iwashima Y., Katsuya T., Ishikawa K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004, 43:1318-1323.
8. Li S., Shin H.J., Ding E.L., van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA : J Am Med Assoc 2009, 302:179-188.
9. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler, Thromb, Vasc Biol 2003, 23:85-89.
10. Aso Y., Yamamoto R., Wakabayashi S., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006, 55:1954-1960.
11. Seino Y., Hirose H., Saito I., Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metab: Clin Exp 2007, 56:1493-1499.
12. von Eynatten M., Humpert P.M., Bluemm A., et al. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis 2008, 199:123-128.
13. Liang K.W., Lee W.J., Lee W.L., et al. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clin Chimica Acta; Int J Clin Chem 2009, 405:114-118.
14. Moroi M., Akter S., Nakazato R., et al. Lower ratio of high-molecular-weight adiponectin level to total may be associated with coronary high-risk plaque. BMC Res Notes 2013, 6:83.
15. Piestrzeniewicz K., Luczak K., Goch J.H. Value of blood adipose tissue hormones concentration-adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction. Neuro Endocrinol Lett 2008, 29:581-588.
16. Inoue T., Kotooka N., Morooka T., et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 2007, 100:569-574.
17. Laughlin G.A., Barrett-Connor E., May S., Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 2007, 165:164-174.
18. Sattar N., Watt P., Cherry L., et al. High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. JClin Endocrinol Metab 2008, 93:1846-1849.
19. Krzyzanowska K., Aso Y., Mittermayer F., et al. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes. Transl Res: J Lab Clin Med 2009, 153:199-203.
20. Lim H.S., Tayebjee M.H., Tan K.T., et al. Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity. Heart (British Card Soc) 2005, 91:1605-1606.
21. Khan U.I., Wang D., Sowers M.R., et al. Race-ethnic differences in adipokine levels: the study of women's Health across the Nation (SWAN). Metab: Clin Exp 2012, 61:1261-1269.
22. Hulver M.W., Saleh O., MacDonald K.G., et al. Ethnic differences in adiponectin levels. Metab: Clin Exp 2004, 53:1-3.
23. Zornitzki T., Reshef N., Ayzenberg O., et al. High-molecular weight adiponectin is associated with coronary artery angiographic findings in Asian Indians. Metab: Clin Exp 2009, 58:632-637.
24. Gensini G.G. Amore meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51:606.
25. Austen W.G., Edwards J.E., Frye R.L., et al. Areporting system on patients evaluated for coronary artery disease. Report of the Ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation 1975, 51:5-40.
26. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
27. Mente A., Razak F., Blankenberg S., et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010, 33:1629-1634.
28. Eglit T., Lember M., Ringmets I., Rajasalu T. Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome. Eur J Endocrinol/Eur Fed Endocrine Soc 2013, 168:385-391.
29. Onat A., Hergenc G., Dursunoglu D., et al. Relatively high levels of serum adiponectin in obese women, a potential indicator of anti-inflammatory dysfunction: relation to sex hormone-binding globulin. Int J Biol Sci 2008, 4:208-214.
30. Hashimoto N., Kanda J., Nakamura T., et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metab: Clin Exp 2006, 55:1653-1657.
31. Filippi E., Sentinelli F., Romeo S., et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age
32. Otsuka F., Sugiyama S., Kojima S., et al. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. JAm Col Cardiol 2006, 48:1155-1162.
33. Broedl U.C., Lebherz C., Lehrke M., et al. Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PloS One 2009, 4:e4733.
34. Li Q., Lu Y., Sun L., et al. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Metab: Clin Exp 2012, 61:1803-1808.
35. Okui H., Hamasaki S., Ishida S., et al. Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides. Int J Cardiol 2008, 126:53-61.
36. Kunita E., Yamamoto H., Kitagawa T., et al. Association between plasma high-molecular-weight adiponectin and coronary plaque characteristics assessed by computed tomography angiography in conditions of visceral adipose accumulation. Circulation J: Off J Jpn Circulation Soc 2012, 76:1687-1696.
37. Kawamoto R., Tabara Y., Kohara K., et al. Smoking status is associated with serum high molecular adiponectin levels in community-dwelling Japanese men. JAtheroscler Thromb 2010, 17:423-430.